Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.


Weaknesses

● With a 2021 P/E ratio at 28.89 times the estimated earnings, the company operates at rather significant levels of earnings multiples.

● Based on current prices, the company has particularly high valuation levels.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The company is not the most generous with respect to shareholders' compensation.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.